Prosecution Insights
Prosecution Insights
11 pending office actions • 10 art units • 11 examiners • 0 of 11 (0%) have an AI response strategy ready • 6 patents granted in the last 365 days
Based on the USPTO statutory response window for each pending office action. 11 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 11 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 3 (27%) |
| §102 only | 2 (18%) |
| No statute on record | 6 (55%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| FISCHER, JOSEPH | 1 | 43.2% | +45.2% |
| SKOKO III, JOHN JOSEPH | 1 | 52.8% | +58.4% |
| REGA, KYLE THOMAS | 1 | 62.4% | +43.9% |
| XIAO, YAN | 1 | 67.9% | +51.5% |
| BUNNER, BRIDGET E | 1 | 64.4% | +19.7% |
| BELYAVSKYI, MICHAIL A | 1 | 63.8% | +27.5% |
| ELENISTE, PIERRE PAUL | 1 | 38.5% | +30.2% |
| HADDAD, MAHER M | 1 | 50.4% | +54.3% |
| BERHANE, SELAM | 1 | 61.3% | +55.5% |
| GAUGER, PAUL RANDALL | 1 | 62.5% | -14.3% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17759388 | ANTI-avB8 INTEGRIN ANTIBODIES FOR USE IN TREATING KIDNEY DISEASE | HADDAD, MAHER M | 149d overdue |
| 17755604 | ANTI IL-33 THERAPEUTIC AGENT FOR TREATING RENAL DISORDERS | BERHANE, SELAM | 77d overdue |
| 18467137 | THERAPEUTIC BINDING MOLECULES | SKOKO III, JOHN JOSEPH | 30d overdue |
| 17962610 | PYRROLOBENZODIAZEPINE ANTIBODY CONJUGATES | ELENISTE, PIERRE PAUL | 1d overdue |
| 18169497 | COMBINATION THERAPIES FOR TREATMENT OF CANCER WITH THERAPEUTIC BINDING MOLECULES | BUNNER, BRIDGET E | 6d |
| 19052168 | POLYPEPTIDES AND USES THEREOF | FISCHER, JOSEPH | 7d |
| 17998388 | FORMULATIONS OF ANTI-IL-33 ANTIBODIES | BELYAVSKYI, MICHAIL A | 19d |
| 18025883 | A Scoring Method for an Anti-B7H4 Antibody-Drug Conjugate Therapy | XIAO, YAN | 33d |
| Art Unit | Apps |
|---|---|
| 1643 | 2 |
| 1658 | 1 |
| 1636 | 1 |
| 1642 | 1 |
| 1647 | 1 |
| 1644 | 1 |
| 1622 | 1 |
| 1641 | 1 |
| 1675 | 1 |
| 1629 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 19052168 | POLYPEPTIDES AND USES THEREOF | FISCHER, JOSEPH | 1658 | Other | Final Rejection | 7d | Pending | Feb 12, 2025 |
| 18467137 | THERAPEUTIC BINDING MOLECULES | SKOKO III, JOHN JOSEPH | 1643 | Other | Final Rejection | 30d overdue | Pending | Sep 14, 2023 |
| 18256768 | HYDROGEN PEROXIDE EVOLVED HOST CELL | REGA, KYLE THOMAS | 1636 | §102 | Non-Final OA | 41d | Pending | Jun 09, 2023 |
| 18025883 | A Scoring Method for an Anti-B7H4 Antibody-Drug Conjugate Therapy | XIAO, YAN | 1642 | §103 | Non-Final OA | 33d | Pending | Mar 11, 2023 |
| 18169497 | COMBINATION THERAPIES FOR TREATMENT OF CANCER WITH THERAPEUTIC BINDING MOLECULES | BUNNER, BRIDGET E | 1647 | Other | Final Rejection | 6d | Pending | Feb 15, 2023 |
| 17998388 | FORMULATIONS OF ANTI-IL-33 ANTIBODIES | BELYAVSKYI, MICHAIL A | 1644 | Other | Final Rejection | 19d | Pending | Nov 10, 2022 |
| 17962610 | PYRROLOBENZODIAZEPINE ANTIBODY CONJUGATES | ELENISTE, PIERRE PAUL | 1622 | Other | Final Rejection | 1d overdue | Pending | Oct 10, 2022 |
| 17759388 | ANTI-avB8 INTEGRIN ANTIBODIES FOR USE IN TREATING KIDNEY DISEASE | HADDAD, MAHER M | 1641 | §102 | Non-Final OA | 149d overdue | Pending | Jul 25, 2022 |
| 17755604 | ANTI IL-33 THERAPEUTIC AGENT FOR TREATING RENAL DISORDERS | BERHANE, SELAM | 1675 | §103 | Final Rejection | 77d overdue | Pending | May 03, 2022 |
| 17599374 | COMPOUNDS AND CONJUGATES THEREOF | GAUGER, PAUL RANDALL | 1629 | §103 | Final Rejection | 53d overdue | Pending | Sep 28, 2021 |
| 17271108 | COMBINATION THERAPY | CANELLA, KAREN A | 1643 | Other | Final Rejection | 53d overdue | Pending | Feb 24, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial